Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Tianjin TEDA Biomedical Engineering Co's EV-to-EBIT for today is
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Tianjin TEDA Biomedical Engineering Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.23 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Tianjin TEDA Biomedical Engineering Co's EV-to-EBITDA for today is:
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Tianjin TEDA Biomedical Engineering Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-13.23 Mil.
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Tianjin TEDA Biomedical Engineering Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €63.30 Mil.
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Tianjin TEDA Biomedical Engineering Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.57 Mil.
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Tianjin TEDA Biomedical Engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-7.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co Enterprise Value Related Terms
Tianjin TEDA Biomedical Engineering Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co Enterprise Value Chart
Tianjin TEDA Biomedical Engineering Co Annual Data
FRA:TJJ vs CTVA, CF, MOS: Enterprise Value Comparison
For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin TEDA Biomedical Engineering Co Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's Enterprise Value falls into.
Tianjin TEDA Biomedical Engineering Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) has a Enterprise Value of €69.87 Mil as of Aug. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors.
Is Tianjin TEDA Biomedical Engineering Co's Enterprise Value too high?
Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's Enterprise Value compare to CTVA and CF?
Tianjin TEDA Biomedical Engineering Co's Enterprise Value of €69.87 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Tianjin TEDA Biomedical Engineering Co and its competitors. Tianjin TEDA Biomedical Engineering Co's current Enterprise Value is €69.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 115% above its estimated fair value. The current Enterprise Value is €69.87 Mil. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (FRA:TJJ), the current Enterprise Value is €69.87 Mil as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin TEDA Biomedical Engineering Co (FRA:TJJ) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued.
The current stock price of €0.02 is trading 115% above its estimated GF Value™ of €0.01.
GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.
Key valuation signals for FRA:TJJ:
Enterprise Value: €69.87 Mil
GF Value™: €0.01 vs. price of €0.02 (115% above fair value)
No single metric tells the full story. See the FRA:TJJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score
Get the complete analysis for FRA:TJJ
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TJJ has been successfully added to your 
